Posterior sinonasal syndrome: pepsin-mediated posterior nasal mucosal injury as a proposed upstream driver of chronic rhinosinusitis. A narrative review of the mechanistic evidence and a testable clinical framework
European Archives of Oto-Rhino-Laryngology · 08.11.2026
DOI: 10.1007/s00405-026-10746-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 08.11.2026. Verfasst von Franklyn R Gergits. Beteiligte Einrichtung: Sinus and Allergy Wellness Center of North Scottsdale, Scottsdale, Arizona, USA. fgergitsdo@gmail.com. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Management of chronic rhinosinusitis (CRS) addresses downstream sinus pathology while upstream mucosal drivers receive little attention. This review evaluates the evidence base for Posterior Sinonasal Syndrome (PSS), a hypothesised framework in which reflux-mediated pepsin injury to the posterior nasal mucosa contributes to disease confined largely to the posterior ethmoid and sphenoid sinuses. METHODS: A narrative review of MEDLINE/PubMed and Google Scholar to September 2026 was performed using predefined search terms and eligibility criteria. Each component of the framework was assigned to one of three evidence tiers: established by human clinical data, derived from experimental study, or proposed by the author and untested. RESULTS: Human clinical data establish that pepsin is present in sinonasal secretions of CRS patients above control levels, and that it is recoverable from middle ear fluid in children. Experimental data establish epithelial uptake at neutral pH and pepsin-induced mitochondrial injury with IL-1α and IL-6 release in nasal epithelium. Because mucociliary transport runs anterior to posterior, posterior disease with patent ostiomeatal complexes is not readily explained by anterior spread, the observation from which this framework arose. A candidate radiologic signature is proposed as an objective criterion. It, the endoscopic findings, the aerosolised delivery route and the neurogenic component are untested hypotheses. CONCLUSION: PSS is offered as a testable framework. A diagnostic pathway is proposed for research use in which treatment response functions as a validation outcome rather than a diagnostic criterion. Prospective studies are required before clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sinus and Allergy Wellness Center of North Scottsdale, Scottsdale, Arizona, USA. fgergitsdo@gmail.com.
Zitieren
APA
Gergits, F. R. (2026). Posterior sinonasal syndrome: pepsin-mediated posterior nasal mucosal injury as a proposed upstream driver of chronic rhinosinusitis. A narrative review of the mechanistic evidence and a testable clinical framework. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-026-10746-3
Vancouver
Gergits FR. Posterior sinonasal syndrome: pepsin-mediated posterior nasal mucosal injury as a proposed upstream driver of chronic rhinosinusitis. A narrative review of the mechanistic evidence and a testable clinical framework. European Archives of Oto-Rhino-Laryngology. 2026. doi:10.1007/s00405-026-10746-3
BibTeX
@article{Gergits2026,
author = {Gergits, Franklyn R},
title = {Posterior sinonasal syndrome: pepsin-mediated posterior nasal mucosal injury as a proposed upstream driver of chronic rhinosinusitis. A narrative review of the mechanistic evidence and a testable clinical framework},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
doi = {10.1007/s00405-026-10746-3}
}
EUVIMED